Barriers to routine G6PD testing prior to treatment with primaquine

BACKGROUND: Primaquine is essential for the radical cure of vivax malaria, however its broad application is hindered by the risk of drug-induced haemolysis in individuals with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Rapid diagnostic tests capable of diagnosing G6PD deficiency are now av...

Descripción completa

Detalles Bibliográficos
Autores principales: Ley, Benedikt, Thriemer, Kamala, Jaswal, Jessica, Poirot, Eugenie, Alam, Mohammad Shafiul, Phru, Ching Swe, Khan, Wasif Ali, Dysoley, Lek, Qi, Gao, Kheong, Chong Chee, Shamsudin, Ummi Kalthom, Chen, Ingrid, Hwang, Jimee, Gosling, Roly, Price, Ric N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553859/
https://www.ncbi.nlm.nih.gov/pubmed/28797255
http://dx.doi.org/10.1186/s12936-017-1981-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553859/
https://www.ncbi.nlm.nih.gov/pubmed/28797255
http://dx.doi.org/10.1186/s12936-017-1981-y

Ejemplares similares